Cancer Incidence and Mortality for All Sites of Cancer, Monroe County, 2007-2011

Source: New York State Cancer Registry

Site of Cancer Incidence Mortality
Males Females Males Females
Average Annual Cases Rate per 100,000 Males 95% CI (+/-) Average Annual Cases Rate per 100,000 Females 95% CI (+/-) Average Annual Deaths Rate per 100,000 Males 95% CI (+/-) Average Annual Deaths Rate per 100,000 Females 95% CI (+/-)
All Invasive Malignant Tumors 2187.0 593.3 11.3 2150.6 464.8 9.0 745.4 207.0 6.7 771.4 155.8 5.1
Oral cavity and pharynx
All Oral cavity and pharynx 58.6 15.2 1.8 39.2 8.3 1.2 11.4 3.0 0.8 4.8 1.0 0.4
Lip 4.0 1.1 0.5 1.6 0.3 0.2 0.2 0.0 0.1 0.0 0.0 0.0
Tongue 18.8 4.8 1.0 11.2 2.4 0.6 1.8 0.5 0.3 0.6 0.1 0.2
Salivary gland 6.4 1.8 0.6 4.8 1.0 0.4 0.8 0.2 0.2 0.8 0.2 0.2
Floor of mouth 2.6 0.7 0.4 1.8 0.3 0.2 0.2 0.0 0.1 0.2 0.0 0.1
Gum & other mouth 7.6 2.0 0.7 11.2 2.4 0.6 0.8 0.2 0.2 1.0 0.2 0.2
Nasopharynx 1.4 0.4 0.3 0.6 0.1 0.2 1.6 0.5 0.3 0.2 0.1 0.1
Tonsil 10.4 2.6 0.7 4.4 1.0 0.4 0.8 0.2 0.2 0.2 0.0 0.1
Oropharynx 2.8 0.7 0.4 1.8 0.4 0.3 2.6 0.7 0.4 1.0 0.2 0.2
Hypopharynx 3.4 0.9 0.4 1.2 0.3 0.2 0.4 0.1 0.2 0.2 0.0 0.1
Other buccal cavity and pharynx 1.2 0.3 0.2 0.6 0.1 0.1 2.2 0.6 0.4 0.6 0.1 0.1
Digestive system
All Digestive system 387.6 104.6 4.7 332.4 68.4 3.4 201.6 55.4 3.5 172.4 33.7 2.3
Esophagus 34.8 9.3 1.4 9.8 2.0 0.6 33.4 9.1 1.4 9.0 1.9 0.6
Stomach 38.6 10.6 1.5 21.4 4.5 0.9 18.2 5.1 1.1 11.2 2.3 0.6
Small intestine 12.6 3.4 0.9 10.6 2.4 0.7 2.6 0.7 0.4 2.4 0.4 0.3
Colorectal 175.8 47.7 3.2 188.8 38.5 2.5 62.0 17.0 1.9 70.4 13.5 1.5
Colon excluding rectum 116.2 31.9 2.6 139.0 27.8 2.1 50.6 14.0 1.8 59.8 11.3 1.3
Cecum 25.6 7.0 1.2 33.6 6.4 1.0            
Appendix 6.8 1.8 0.6 4.2 0.9 0.4            
Ascending colon 18.8 5.3 1.1 32.6 6.3 1.0            
Hepatic flexure 5.2 1.4 0.6 6.6 1.3 0.5            
Transverse colon 10.6 3.0 0.8 13.4 2.7 0.7            
Splenic flexure 2.8 0.8 0.4 4.0 0.8 0.3            
Descending colon 7.4 2.0 0.7 7.0 1.5 0.5            
Sigmoid colon 33.2 8.9 1.4 30.0 6.5 1.1            
Large intestine, NOS 5.8 1.7 0.6 7.6 1.5 0.5            
Rectum & rectosigmoid 59.6 15.8 1.8 49.8 10.7 1.4 11.4 3.0 0.8 10.6 2.2 0.6
Rectosigmoid junction 15.2 4.1 0.9 13.8 2.9 0.7            
Rectum 44.4 11.7 1.6 36.0 7.8 1.2            
Anus, anal canal & anorectum 6.4 1.6 0.6 9.4 2.0 0.6 1.2 0.3 0.3 1.0 0.2 0.2
Liver and intrahepatic bile duct 44.6 11.7 1.6 14.8 3.2 0.8 29.8 8.2 1.3 17.6 3.5 0.8
Liver 40.4 10.5 1.5 12.2 2.7 0.7 21.6 5.8 1.1 9.4 1.9 0.6
Intrahepatic bile duct 4.2 1.2 0.5 2.6 0.6 0.3 8.2 2.3 0.7 8.2 1.6 0.5
Gallbladder 3.2 0.9 0.5 3.4 0.7 0.3 1.4 0.4 0.3 1.8 0.4 0.2
Other biliary 10.2 2.7 0.7 7.4 1.4 0.5 2.0 0.5 0.3 1.4 0.2 0.2
Pancreas 56.0 15.1 1.8 56.0 11.4 1.4 49.4 13.5 1.7 53.6 10.4 1.3
Retroperitoneum 3.2 0.9 0.4 2.6 0.6 0.3 0.4 0.1 0.1 0.4 0.1 0.1
Peritoneum, omentum & mesentery 0.2 0.0 0.1 5.8 1.2 0.5 0.4 0.1 0.1 1.0 0.2 0.2
Other digestive organs 2.0 0.6 0.4 2.4 0.5 0.3 0.8 0.3 0.2 2.6 0.5 0.3
Respiratory system
All Respiratory system 313.8 85.5 4.3 294.6 62.1 3.2 223.4 61.4 3.7 207.6 43.1 2.7
Nasal cavity, middle ear & sinuses 3.6 1.0 0.5 3.2 0.7 0.3 0.8 0.2 0.2 1.2 0.2 0.2
Larynx 25.2 6.7 1.2 6.0 1.2 0.4 8.2 2.2 0.7 3.4 0.7 0.3
Lung and bronchus 284.0 77.5 4.1 285.2 60.1 3.2 214.2 58.9 3.6 203.0 42.2 2.7
Pleura 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Trachea, mediastinum, other respiratory 1.0 0.3 0.3 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0
Soft tissue, bone, and skin
Bones & joints 4.6 1.2 0.5 3.8 0.9 0.4 2.8 0.8 0.4 1.2 0.3 0.2
Soft tissue (including heart) 15.2 4.2 0.9 14.0 3.3 0.8 5.2 1.4 0.5 6.8 1.4 0.5
Skin~ 101.6 28.2 2.5 85.0 19.6 1.9 20.0 5.5 1.1 10.2 2.0 0.6
Melanoma of the skin 93.0 25.8 2.4 78.2 18.2 1.9 14.0 3.8 0.9 7.0 1.5 0.5
Breast
Breast 5.2 1.4 0.6 641.0 140.9 5.0 1.6 0.5 0.3 113.2 23.1 2.0
Female genital system
All Female genital system       240.4 51.8 3.0       80.8 16.4 1.6
Cervix uteri       23.6 5.7 1.1       6.6 1.5 0.5
Corpus uterus and NOS       141.8 30.2 2.3       25.2 4.9 0.9
Ovary       54.6 11.8 1.4       44.0 9.0 1.2
Vagina       2.6 0.5 0.3       0.2 0.1 0.1
Vulva       13.2 2.7 0.7       3.4 0.6 0.3
Other female genital organs       4.6 1.0 0.4       1.4 0.3 0.2
Male genital system
All Male genital system 663.6 176.0 6.1       68.6 20.0 2.1      
Prostate 638.4 168.7 6.0       66.2 19.3 2.1      
Testis 21.0 6.2 1.2       0.8 0.2 0.2      
Penis 3.6 1.0 0.5       1.2 0.4 0.3      
Other male genital organs 0.6 0.2 0.2       0.4 0.1 0.2      
Urinary system
All Urinary system 269.8 75.0 4.1 109.0 22.7 2.0 55.2 15.5 1.9 22.8 4.3 0.8
Urinary bladder (including in situ) 162.0 46.0 3.2 49.0 10.0 1.3 32.4 9.2 1.4 9.6 1.7 0.5
Kidney and renal pelvis 102.0 27.3 2.4 56.8 12.2 1.5 21.6 5.9 1.1 12.2 2.4 0.6
Ureter 2.4 0.7 0.4 1.2 0.3 0.2 0.6 0.2 0.2 0.0 0.0 0.0
Other urinary organs 3.4 1.0 0.5 2.0 0.4 0.2 0.6 0.2 0.2 1.0 0.2 0.2
Eye & orbit
Eye & orbit 1.2 0.3 0.3 1.6 0.3 0.2 0.0 0.0 0.0 0.6 0.1 0.1
Brain and central nervous system
All Brain / other nervous system (all behaviors) 57.6 16.0 1.9 98.4 22.0 2.0 21.4 6.0 1.2 20.8 4.4 0.9
Malignant brain / other nervous system 25.0 7.2 1.3 24.6 5.8 1.1 18.4 5.2 1.1 16.0 3.4 0.8
Malignant brain 24.2 6.9 1.3 22.8 5.3 1.0            
Malignant other nervous system 0.8 0.2 0.2 1.8 0.5 0.3            
Benign brain / other nervous system* 32.6 8.8 1.4 73.8 16.3 1.7 3.0 0.9 0.4 4.8 1.0 0.4
Benign brain 2.8 0.8 0.4 5.2 1.3 0.5            
Benign other nervous system 29.8 8.1 1.3 68.6 14.9 1.6            
Endocrine system
All Endocrine system 31.6 8.5 1.4 80.4 20.2 2.0 2.4 0.7 0.4 4.4 0.9 0.4
Thyroid 29.2 7.9 1.3 76.8 19.3 2.0 1.6 0.4 0.3 2.4 0.4 0.2
Other endocrine (including thymus) 2.4 0.7 0.4 3.6 0.9 0.4 0.8 0.2 0.2 2.0 0.5 0.3
Lymphomas
All Lymphomas 111.2 30.7 2.6 103.6 22.7 2.0 30.2 8.4 1.4 29.8 5.9 1.0
Hodgkin lymphoma 11.4 3.2 0.9 14.2 3.7 0.9 1.6 0.5 0.3 2.0 0.5 0.3
Non-Hodgkin lymphomas 99.8 27.5 2.4 89.4 19.0 1.8 28.6 7.9 1.3 27.8 5.4 0.9
Myeloma
All Myeloma 33.0 8.8 1.4 25.2 5.2 0.9 15.8 4.3 1.0 13.6 2.8 0.7
Leukemias
All Leukemias 68.0 18.8 2.0 60.0 13.3 1.6 34.4 9.7 1.5 30.4 6.2 1.0
Lymphocytic leukemias 36.8 10.0 1.5 28.8 6.3 1.1 11.0 3.1 0.8 8.0 1.6 0.5
Acute lymphocytic leukemia 3.2 0.9 0.4 4.0 1.1 0.5 1.8 0.5 0.4 2.2 0.6 0.3
Chronic lymphocytic leukemia 29.8 8.1 1.3 23.0 4.9 0.9 8.8 2.5 0.7 4.8 0.8 0.3
Other lymphocytic leukemias 3.8 1.0 0.5 1.8 0.4 0.3 0.4 0.1 0.1 1.0 0.2 0.2
Myeloid and monocytic leukemias 29.0 8.1 1.3 29.0 6.5 1.1 17.4 4.9 1.0 17.8 3.7 0.8
Acute myeloid leukemia 19.2 5.3 1.1 19.6 4.4 0.9 15.2 4.3 1.0 14.8 3.1 0.7
Acute monocytic leukemia 1.0 0.3 0.2 0.6 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.1
Chronic myeloid leukemia 8.0 2.3 0.7 8.4 1.8 0.6 1.8 0.5 0.3 1.6 0.3 0.2
Other myeloid/monocytic leukemias 0.8 0.2 0.2 0.4 0.1 0.2 0.4 0.1 0.1 1.2 0.2 0.2
Other leukemias 2.2 0.7 0.4 2.2 0.5 0.3 6.0 1.7 0.6 4.6 0.9 0.4
Other acute leukemias 1.2 0.3 0.3 0.8 0.2 0.2 3.6 1.0 0.5 2.0 0.4 0.3
Aleukemic, subacute, leukemia NOS 1.0 0.3 0.3 1.4 0.3 0.3 2.4 0.7 0.4 2.6 0.5 0.3
Mesothelioma
Mesothelioma 7.8 2.3 0.7 1.6 0.4 0.3            
Kaposi sarcoma
Kaposi sarcoma 1.6 0.4 0.3 0.0 0.0 0.0            
Myelodysplastic syndromes
Myelodysplastic syndromes 32.2 9.4 1.5 26.4 5.1 0.9            
Chronic myeloproliferative disorders^
Chronic myeloproliferative disorders^ 14.4 4.1 1.0 18.8 4.1 0.8            
Ill defined and unspecified sites
Ill defined and unspecified sites 41.0 11.3 1.6 49.0 9.6 1.2 54.4 15.4 1.9 56.8 11.2 1.3

Key

Symbol Meaning
~ Incidence of skin cancer excludes basal and squamous cell cancers.
* Brain and other nervous system tumors with benign or uncertain behaviors are not included in the total for all invasive malignant tumors.
^ Tumors with a histology of 9963 or 9964 are included under Aleukemic, Subacute, Leukemia NOS, instead of Chronic Myeloproliferative Disorder.

Notes

  • Incidence data are provisional, November 2013.
  • Rates are per 100,000 persons, age-adjusted to the 2000 US standard population, with 95% confidence intervals.
  • Rates based on fewer than 4 cases or deaths per year are unstable and should be used with caution. NOS = Not otherwise specified.